FIELD: biotechnology. SUBSTANCE: invention aims to selectively eliminate cells infected with hepatitis C virus or infection RNA thereof. For that, into cells is introduced plasmid pcDT encoding pseudo hepatitis C virus "-" RNA and capable of orienting synthesis of A subunit of diphtheria toxin in hepatitis C virus-infected cells. Such RNA does not kill sound cells and is incapable of translation. EFFECT: enlarged resource for preparing antihepatitis vaccines. 3 cl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SELECTIVELY KILLING CELLS | 1999 |
|
RU2158139C1 |
| THERAPEUTIC AGENT FOR TREATING VIRAL HEPATITIS C | 2014 |
|
RU2568872C1 |
| CODING DNA (cDNA) FOR MAKING VIRUS-LIKE PARTICLES OF HEPATITIS C VIRUS, METHOD FOR MAKING VIRUS-LIKE PARTICLES AND BASED PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2375449C2 |
| IMPROVING GENETIC CONSTRUCTS FOR PROVIDING HIGH EFFICACY OF ANTI-HIV THERAPY | 2013 |
|
RU2533817C1 |
| RECOMBINANT PLASMID DNA "pДТИ-23", METHOD OF PREPARING RECOMBINANT PLASMID DNA "pДТИ-23" AND STRAIN OF BACTERIUM ESCHERICHIA COLI CONTAINING RECOMBINANT PLASMID DNA "pДТИ-23" - A PRODUCER OF THE FUSED PROTEIN DTI-2 | 1993 |
|
RU2077585C1 |
| COMPOSITION, METHOD FOR PRODUCING ARTIFICIAL ORDERED AND REPETITIONS-CONTAINING ANTIGEN MATRIX, METHOD FOR CARRYING OUT THERAPY AND IMMUNIZATION | 1999 |
|
RU2245163C2 |
| RECOMBINANT RNA FRAGMENT (VARIANTS), RIBONUCLEOPROTEID COMPLEX (VARIANTS), PLASMID | 1990 |
|
RU2132877C1 |
| GENETIC MAKE-UPS FOR ANTI-HIV THERAPY | 2010 |
|
RU2426788C1 |
| RECOMBINANT PLASMID DNA PVAX2 FOR TRANSFER AND EXPRESSION OF HEPATITIS B SURFACE ANTIGEN GENE IN VARIOLOVACCINE VIRUS GENOME AND A STRAIN OF VARIOLOVACCINE VIRUS EXPRESSING THE SURFACE ANTIGEN OF HEPATITIS B VIRUS | 1985 |
|
SU1354709A1 |
| RECOMBINANT PLASMID DNA PYAIA05 FOR MARKING AND IDENTIFICATION OF THE THIRD HUMAN CHROMOSOME | 1994 |
|
RU2087533C1 |
